Overall, our findings suggest that the deregulated activity of E2F in cancer cells causes increased activation of the Kpnβ1 and Kpnα2 promoters, leading to elevated levels of these proteins, and ultimately impacting the cancer phenotype. The gene discussed is KPNB1; the disease is cancer.